Location History:
- Severna Park, MD (US) (2016 - 2019)
- Bethesda, MD (US) (2020 - 2023)
Company Filing History:
5 out of 122 
5 out of 3,539 
5 out of 1,932 
Years Active: 2016-2023
Title: Michael R Erdos: Innovator in Oligonucleotide Research
Introduction
Michael R Erdos is a prominent inventor based in Severna Park, MD (US). He has made significant contributions to the field of oligonucleotide research, holding a total of five patents. His work focuses on developing innovative solutions for genetic disorders.
Latest Patents
Among his latest patents are the "Oligonucleotide analogues targeting human LMNA." These patents provide LMNA-targeted antisense oligonucleotides aimed at reducing the expression of aberrantly spliced LMNA mRNA isoforms that encode progerin. This research is crucial for addressing conditions related to the LMNA gene.
Career Highlights
Michael has worked with notable organizations such as Sarepta Therapeutics, Inc. and the National Institutes of Health, a component of the US Department of Health & Human Services. His career reflects a commitment to advancing medical science through innovative research.
Collaborations
Michael has collaborated with esteemed colleagues, including Ryszard M Kole and Francis S Collins. These partnerships have further enhanced the impact of his research in the scientific community.
Conclusion
Michael R Erdos is a distinguished inventor whose work in oligonucleotide research has the potential to transform the treatment of genetic disorders. His contributions continue to influence the field and inspire future innovations.